Development and Validation of Risk Prediction Model for In-hospital Mortality Among Patients Hospitalized With Acute Exacerbation Chronic Obstructive Pulmonary Disease Between 2015 and 2019

被引:10
作者
Dong, Fen [1 ,2 ,3 ,4 ]
Ren, Xiaoxia [2 ,3 ,4 ]
Huang, Ke [2 ,3 ,4 ]
Wang, Yanyan [5 ]
Jiao, Jianjun [6 ]
Yang, Ting [2 ,3 ,4 ]
机构
[1] China Japan Friendship Hosp, Inst Clin Med Sci, Beijing, Peoples R China
[2] China Japan Friendship Hosp, Dept Pulm & Crit Care Med, Beijing, Peoples R China
[3] Natl Clin Res Ctr Resp Dis, Beijing, Peoples R China
[4] Chinese Acad Med Sci, Inst Resp Med, Beijing, Peoples R China
[5] China Japan Friendship Hosp, Dept Med Records, Beijing, Peoples R China
[6] China Japan Friendship Hosp, Dept Med Adm, Beijing, Peoples R China
基金
国家重点研发计划;
关键词
prediction model; development; validation; in-hospital mortality; acute exacerbation of COPD;
D O I
10.3389/fmed.2021.630870
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In patients with chronic obstructive pulmonary disease (COPD), acute exacerbations affect patients' health and can lead to death. This study was aimed to develop a prediction model for in-hospital mortality in patients with acute exacerbations of COPD (AECOPD). Method: A retrospective study was performed in patients hospitalized for AECOPD between 2015 and 2019. Patients admitted between 2015 and 2017 were included to develop model and individuals admitted in the following 2 years were included for external validation. We analyzed variables that were readily available in clinical practice. Given that death was a rare outcome in this study, we fitted Firth penalized logistic regression. C statistic and calibration plot quantified the model performance. Optimism-corrected C statistic and slope were estimated by bootstrapping. Accordingly, the prediction model was adjusted and then transformed into risk score. Result: Between 2015 and 2017, 1,096 eligible patients were analyzed, with a mean age of 73 years and 67.8% male. The in-hospital mortality was 2.6%. Compared to survivors, non-survivors were older, more admitted from emergency, more frequently concomitant with respiratory failure, pneumothorax, hypoxic-hypercarbic encephalopathy, and had longer length of stay (LOS). Four variables were included into the final model: age, respiratory failure, pneumothorax, and LOS. In internal validation, C statistic was 0.9147, and the calibration slope was 1.0254. Their optimism-corrected values were 0.90887 and 0.9282, respectively, indicating satisfactory discrimination and calibration. When externally validated in 700 AECOPD patients during 2018 and 2019, the model demonstrated good discrimination with a C statistic of 0.8176. Calibration plot illustrated a varying discordance between predicted and observed mortality. It demonstrated good calibration in low-risk patients with predicted mortality rate <= 10% (P = 0.3253) but overestimated mortality in patients with predicted rate >10% (P < 0.0001). The risk score of 20 was regarded as a threshold with an optimal Youden index of 0.7154. Conclusion: A simple prediction model for AECOPD in-hospital mortality has been developed and externally validated. Based on available data in clinical setting, the model could serve as an easily used instrument for clinical decision-making. Complications emerged as strong predictors, underscoring an important role of disease management in improving patients' prognoses during exacerbation episodes.
引用
收藏
页数:9
相关论文
共 27 条
  • [1] Mortality after hospitalization for COPD
    Almagro, P
    Calbo, E
    de Echagüen, AO
    Barreiro, B
    Quintana, S
    Heredia, JL
    Garau, J
    [J]. CHEST, 2002, 121 (05) : 1441 - 1448
  • [2] Respiratory failure in chronic obstructive pulmonary disease
    Calverley, PMA
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2003, 22 : 26S - 30S
  • [3] Comorbidities of COPD
    Cavailles, Arnaud
    Brinchault-Rabin, Graziella
    Dixmier, Adrien
    Goupil, Francois
    Gut-Gobert, Christophe
    Marchand-Adam, Sylvain
    Meurice, Jean-Claude
    Morel, Hugues
    Person-Tacnet, Christine
    Leroyer, Christophe
    Diot, Patrice
    [J]. EUROPEAN RESPIRATORY REVIEW, 2013, 22 (130) : 454 - 475
  • [4] COPD exacerbations 1: Epidemiology
    Donaldson, GC
    Wedzicha, JA
    [J]. THORAX, 2006, 61 (02) : 164 - 168
  • [5] COPD in China The Burden and Importance of Proper Management
    Fang, Xiaocong
    Wang, Xiangdang
    Bai, Chunxue
    [J]. CHEST, 2011, 139 (04) : 920 - 929
  • [6] PREDICTING MORTALITY OF PATIENTS HOSPITALIZED FOR ACUTELY EXACERBATED CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
    FUSO, L
    INCALZI, RA
    PISTELLI, R
    MUZZOLON, R
    VALENTE, S
    PAGLIARI, G
    GLIOZZI, F
    CIAPPI, G
    [J]. AMERICAN JOURNAL OF MEDICINE, 1995, 98 (03) : 272 - 277
  • [7] Comorbidity in patients with chronic obstructive pulmonary disease in family practice: a cross sectional study
    Garcia-Olmos, Luis
    Alberquilla, Angel
    Ayala, Victoria
    Garcia-Sagredo, Pilar
    Morales, Leticia
    Carmona, Montserrat
    de Tena-Davila, Maria Jose
    Pascual, Mario
    Munoz, Adolfo
    Salvador, Carlos H.
    Monteagudo, Jose L.
    [J]. BMC FAMILY PRACTICE, 2013, 14
  • [8] Global Burden of Disease Collaborative Network, 2018, GLOBAL BURDEN DIS ST
  • [9] Statistical Primer: developing and validating a risk prediction model
    Grant, Stuart W.
    Collins, Gary S.
    Nashef, Samer A. M.
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2018, 54 (02) : 203 - 208
  • [10] Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit
    Hartl, Sylvia
    Luis Lopez-Campos, Jose
    Pozo-Rodriguez, Francisco
    Castro-Acosta, Ady
    Studnicka, Michael
    Kaiser, Bernhard
    Roberts, C. Michael
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (01) : 113 - 121